DiabetOmics is developing proteomic biomarker diagnostics for diabetes. They are using unbiased biomarker discovery techniques to find diabetes indicators in the uring and saliva.
DiabetOmics
Organization
Address
We can also tell you DiabetOmics is a…
If you know more about DiabetOmics, you can add more facts here »
Similar topics in Freebase
-
Evogen
Evogen is developing PCR based molecular diagnostic systems for biodefense, clinical, research, animal health, etc. -
HX Diagnostics
HX Diagnostics, Inc. is a San Francisco Bay Area diagnostics company with a mission to be a global leader in rapid diagnostics for seasonal and emerging infectious diseases. The company is focused on the development and commercialization of seasonal and pandemic influenza assays that will allow... -
Pathwork Diagnostics
Pathwork Dx is developing microarray based diagnostics for oncology. Pathwork has developed a tissue of origin test using a tumor's genetic information to accurately identify the tissue of origin of challenging tumors. -
MicroPhage Inc.
MicroPhage is developing rapid bacterial diagnostics, focused on bacterial identification and antbiotic susceptibility. -
Bayer
Bayer AG (German pronunciation: [ˈbaɪɐ]) is a chemical and pharmaceutical company founded in Barmen (today a part of Wuppertal), Germany in 1863. It is headquartered in Leverkusen, North Rhine-Westphalia, Germany and well known for its original brand of aspirin. Bayer AG was founded in Barmen ... -
diaDexus
diaDexus is developing diagnostics for the cardiovascular field. -
Applied Genomics
Applied Genomics develops diagnostics for the treatment of cancer. -
Amylin Pharmaceuticals
Amylin Pharmaceuticals is a biopharmaceutical company based in San Diego, CA, that was founded in 1987. The company is engaged in the discovery, development and commercialization of drug candidates for the treatment of diabetes, obesity and other diseases. Currently, Amylin produces three drugs,... -
GI Dynamics
GI Dynamics is developing surgical medical devices to treat diabetes. Their primary product the EndoBarrier lines a portion of the gastrointestinal tract to modify a patients metabolism. -
T2 Biosystems
T2 Biosystems is developing Point-of-Care diagnostic systems.
